Corrigendum: Differential transcriptional responses to Ebola and Marburg virus infection in bat and human cells (Scientific Reports (2016) 6 (34589) DOI: 10.1038/srep34589);Differential transcriptional responses to Ebola and Marburg virus infection in bat and human cells

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Hölzer, Martin ^a   Krähling, Verena ^b,c   Amman, Fabian ^d   Barth, Emanuel ^a,e   Bernhart, Stephan H ^d   Carmelo, Victor A O ^f   Collatz, Maximilian ^a,b   Doose, Gero ^d   Eggenhofer, Florian ^g,h   Ewald, Jan ^a   Fallmann, Jörg ^d   Feldhahn, Lasse M ^i,j,k   Fricke, Markus ^a   Gebauer, Juliane ^a   Gruber, Andreas J ^l   Hufsky, Franziska ^a   Indrischek, Henrike ^d   Kanton, Sabina ^d   Linde, Jörg ^m   Mostajo, Nelly ^a,b   Ochsenreiter, Roman ^g   Riege, Konstantin ^a   Rivarola Duarte, Lorena ^d,j   Sahyoun, Abdullah H ^a,d,n,o   Saunders, Sita J ^h   Seemann, Stefan E ^f   Tanzer, Andrea ^g   Vogel, Bertram ^a,b   Wehner, Stefanie ^a,p   Wolfinger, Michael T ^g,q   Backofen, Rolf ^f,h   Gorodkin, Jan ^f   Grosse, Ivo ^i,j   Hofacker, Ivo ^f,g   Hoffmann, Steve ^d   Kaleta, Christoph ^r   Stadler, Peter F ^d,f   Becker, Stephan ^b,c   Marz, Manja ^a,e   more..

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

^c UNIVERSITY HOSPITAL MARBURG   (Germany)

^d UNIVERSITY OF LEIPZIG   (Germany)

^e FRITZ LIPMANN INSTITUTE   (Germany)

^f UNIVERSITY OF COPENHAGEN   (Denmark)

^g UNIVERSITY OF VIENNA   (Austria)

^h UNIVERSITY OF FREIBURG   (Germany)

ⁱ MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^j HELMHOLTZ CENTRE FOR ENVIRONMENTAL RESEARCH UFZ   (Germany)

^k GERMAN CENTRE FOR INTEGRATIVE BIODIVERSITY RESEARCH IDIV HALLE JENA LEIPZIG   (Germany)

^l UNIVERSITY OF BASEL   (Switzerland)

^m HANS KNÖLL INSTITUTE   (Germany)

ⁿ LEBANESE UNIVERSITY   (Libyan Arab Jamahiriya)

^o JOHANNES GUTENBERG UNIVERSITY   (Germany)

^p UNIVERSITY OF STIRLING   (United Kingdom)

^q Medical University of Vienna   (Austria)

^r UNIVERSITY OF KIEL   (Germany)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL; BAT; EBOLA HEMORRHAGIC FEVER; EBOLAVIRUS; GENE EXPRESSION REGULATION; GENETIC TRANSCRIPTION; HUMAN; MARBURG HEMORRHAGIC FEVER; MARBURGVIRUS; METABOLISM; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANIMALS; CELL LINE, TUMOR; CHIROPTERA; EBOLAVIRUS; GENE EXPRESSION REGULATION; HEMORRHAGIC FEVER, EBOLA; HUMANS; MARBURG VIRUS DISEASE; MARBURGVIRUS; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 84991066577     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep39421     Document Type: Erratum

References (97)

1. Feldmann, H., Klenk, H. D. & Sanchez, A. Molecular biology and evolution of filoviruses. Arch. Virol. Suppl. 7, 81-100 (1993).
2. Pourrut, X. et al. Large serological survey showing cocirculation of Ebola and Marburg viruses in Gabonese bat populations, and a high seroprevalence of both viruses in Rousettus aegyptiacus. BMC Infect. Dis. 9, 159 (2009).
3. Saez, A. M. et al. Investigating the zoonotic origin of the West African Ebola epidemic. EMBO Mol Med (2014).
4. Towner, J. S. et al. Marburg virus infection detected in a common African bat. PLoS ONE 2, e764 (2007).
5. Towner, J. S. et al. Isolation of genetically diverse Marburg viruses from Egyptian fruit bats. PLoS Pathog. 5, e1000536 (2009).
6. Amman, B. R. et al. Seasonal pulses of Marburg virus circulation in juvenile Rousettus aegyptiacus bats coincide with periods of increased risk of human infection. PLoS Pathog. 8, e1002877 (2012).
7. Paweska, J. T. et al. Virological and serological findings in Rousettus aegyptiacus experimentally inoculated with vero cells-adapted hogan strain of Marburg virus. PLoS ONE 7, e45479 (2012).
8. Amman, B. R. et al. Oral shedding of Marburg virus in experimentally infected egyptian fruit bats (Rousettus aegyptiacus). J. Wildl. Dis. (2014).
9. Ansari, A. A. Clinical features and pathobiology of Ebolavirus infection. J. Autoimmun. 55C, 1-9 (2014).
10. Barrenas, F. et al. Next generation sequencing reveals a controlled immune response to Zaire Ebola virus challenge in cynomolgus macaques immunized with VSV?G/EBOVgp. Clinical and Vaccine Immunology CVI-00733 (2015).
11. Cilloniz, C. et al. Functional genomics reveals the induction of inflammatory response and metalloproteinase gene expression during lethal Ebola virus infection. J. Virol. 85, 9060-9068 (2011).
12. Kash, J. C. et al. Global suppression of the host antiviral response by Ebola- and Marburgviruses: increased antagonism of the type I interferon response is associated with enhanced virulence. J. Virol. 80, 3009-3020 (2006).
13. Yen, J. Y. et al. Therapeutics of Ebola hemorrhagic fever: whole-genome transcriptional analysis of successful disease mitigation. J. Infect. Dis. 204 Suppl 3,S1043-1052 (2011).
14. Wahl-Jensen, V. et al. Ebola virion attachment and entry into human macrophages profoundly effects early cellular gene expression. PLoS Negl Trop Dis 5, e1359 (2011).
15. Ludwig, S. Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections. Biol. Chem. 392, 837-847 (2011).
16. Ludwig, S. Will omics help to cure the flu? Trends Microbiol. 22, 232-233 (2014).
17. Nakabayashi, H., Taketa, K., Miyano, K., Yamane, T. & Sato, J. Growth of human hepatoma cells lines with differentiated functions in chemically defined medium. Cancer Res. 42, 3858-3863 (1982).
18. Jordan, I., Munster, V. J. & Sandig, V. Authentication of the R06E fruit bat cell line. Viruses 4, 889-900 (2012).
19. Timen, A. et al. Response to imported case of Marburg hemorrhagic fever, the Netherland. Emerging Infect. Dis. 15, 1171-1175 (2009).
20. Martines, R. B., Ng, D. L., Greer, P. W., Rollin, P. E. & Zaki, S. R. Tissue and cellular tropism, pathology and pathogenesis of Ebola and Marburg Viruses. J. Pathol. (2014).
21. Panning, M. et al. Diagnostic reverse-transcription polymerase chain reaction kit for filoviruses based on the strain collections of all European biosafety level 4 laboratories. J. Infect. Dis. 196 Suppl 2, 199-204 (2007).
22. Schmieder, R. & Edwards, R. Quality control and preprocessing of metagenomic datasets. Bioinformatics 27, 863-864 (2011).
23. Andrews, S. et al. FastQC: A quality control tool for high throughput sequence data. Reference Source (2010).
24. Kent, W. J. et al. The human genome browser at UCSC. Genome Res 12, 996-1006 (2002).
25. Gire, S. K. et al. Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak. Science 345, 1369-1372 (2014).
26. Zerbino, D. R. & Birney, E. Velvet: algorithms for de novo short read assembly using de Bruijn graphs. Genome Res 18, 821-829 (2008).
27. Schulz, M. H., Zerbino, D. R., Vingron, M. & Birney, E. Oases: robust de novo RNA-seq assembly across the dynamic range of expression levels. Bioinformatics 28, 1086-1092 (2012).
28. Simpson, J. T. et al. ABySS: a parallel assembler for short read sequence data. Genome Res 19, 1117-1123 (2009).
29. Robertson, G. et al. De novo assembly and analysis of RNA-seq data. Nat Methods 7, 909-912 (2010).
30. Xie, Y. et al. SOAPdenovo-trans: de novo transcriptome assembly with short RNA-Seq reads. Bioinformatics 30, 1660-1666 (2014).
31. Grabherr, M. G. et al. Full-length transcriptome assembly from RNA-Seq data without a reference genome. Nat Biotechnol 29, 644-652 (2011).
32. Chevreux, B. et al. Using the miraEST assembler for reliable and automated mRNA transcript assembly and SNP detection in sequenced ESTs. Genome Res 14, 1147-1159 (2004).
33. Li, W. & Godzik, A. Cd-hit: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics 22, 1658-1659 (2006).
34. Lee, A. K. et al. De novo transcriptome reconstruction and annotation of the Egyptian rousette bat. BMC genomics 16, 1 (2015).
35. Gurevich, A., Saveliev, V., Vyahhi, N. & Tesler, G. QUAST: quality assessment tool for genome assemblies. Bioinformatics 29, 1072-1075 (2013).
36. Trapnell, C., Pachter, L. & Salzberg, S. L. Tophat: discovering splice junctions with RNA-Seq. Bioinformatics 25, 1105-1111 (2009).
37. Hoffmann, S. et al. Fast mapping of short sequences with mismatches, insertions and deletions using index structures. PLoS Comput Biol 5, e1000502 (2009).
38. Wolfinger, M. T., Fallmann, J., Eggenhofer, F. & Amman, F. ViennaNGS: A toolbox for building efficient next-generation sequencing analysis pipelines. F1000Research 4 (2015).
39. Trapnell, C. et al. Transcript assembly and quantification by RNA-Seq reveals unannotated transcripts and isoform switching during cell differentiation. Nat Biotechnol 28, 511-515 (2010).
40. Quinlan, A. R. & Hall, I. M. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics 26, 841-842 (2010).
41. Anders, S. & Huber, W. Differential expression analysis for sequence count data. Genome Biol 11, R106 (2010).
42. Thorvaldsdóttir, H., Robinson, J. T. & Mesirov, J. P. Integrative genomics viewer (IGV): high-performance genomics data visualization and exploration. Brief Bioinform 14, 178-192 (2013).
43. Kanehisa, M. & Goto, S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 28, 27-30 (2000).
44. Benjamini, Y. & Hochberg, Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. Journal of the Royal Statistical Society. Series B (Methodological) 57, 289-300 (1995).
45. Luo, W., Friedman, M. S., Shedden, K., Hankenson, K. D. & Woolf, P. J. GAGE: generally applicable gene set enrichment for pathway analysis. BMC Bioinformatics 10, 161 (2009).
46. Luo, W. & Brouwer, C. Pathview: an R/Bioconductor package for pathway-based data integration and visualization. Bioinformatics 29, 1830-1831 (2013).
47. Balwierz, P. J. et al. ISMARA: automated modeling of genomic signals as a democracy of regulatory motifs. Genome research 24, 869-84 (2014).
48. de Wilde, J. et al. Alterations in AP-1 and AP-1 regulatory genes during HPV-induced carcinogenesis. Cell. Oncol. 30, 77-87 (2008).
49. Varshney, B. & Lal, S. K. SARS-CoV accessory protein 3b induces AP-1 transcriptional activity through activation of JNK and ERK pathways. Biochemistry 50, 5419-5425 (2011).
50. Kuri, T. et al. Interferon priming enables cells to partially overturn the SARS coronavirus-induced block in innate immune activation. J. Gen. Virol. 90, 2686-2694 (2009).
51. Cardenas, W. B. et al. Ebola virus VP35 protein binds double-stranded RNA and inhibits alpha/beta interferon production induced by RIG-I signaling. J. Virol. 80, 5168-5178 (2006).
52. Ramanan, P. et al. Filoviral immune evasion mechanisms. Viruses 3, 1634-1649 (2011).
53. Luthra, P. et al. Mutual antagonism between the Ebola virus VP35 protein and the RIG-I activator PACT determines infection outcome. Cell Host Microbe 14, 74-84 (2013).
54. Schmitz, M. L., Kracht, M. & Saul, V. V. The intricate interplay between RNA viruses and NF-B. Biochim. Biophys. Acta 1843, 2754-2764 (2014).
55. Reikine, S., Nguyen, J. B. & Modis, Y. Pattern Recognition and Signaling Mechanisms of RIG-I and MDA5. Front Immunol 5, 342 (2014).
56. Gack, M. U. et al. TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity. Nature 446, 916-920 (2007).
57. Ozato, K., Shin, D. M., Chang, T. H. & Morse, H. C. TRIM family proteins and their emerging roles in innate immunity. Nat. Rev. Immunol. 8, 849-860 (2008).
58. Olejnik, J. et al. Ebola virus does not block apoptotic signaling pathways. J Virol 87, 5384-5396 (2013).
59. Jun, J. I. & Lau, L. F. Taking aim at the extracellular matrix: CCN proteins as emerging therapeutic targets. Nat Rev Drug Discov 10, 945-963 (2011).
60. Goda, C. et al. Involvement of IL-32 in activation-induced cell death in T cells. International immunology 18, 233-240 (2006).
61. Wauquier, N., Becquart, P., Padilla, C., Baize, S. & Leroy, E. M. Human fatal zaire ebola virus infection is associated with an aberrant innate immunity and with massive lymphocyte apoptosis. PLoS Negl Trop Dis 4 (2010).
62. Li, W. et al. Activation of interleukin-32 pro-inflammatory pathway in response to influenza A virus infection. PLoS One 3, e1985 (2008).
63. Li, W. et al. IL-32: a host proinflammatory factor against influenza viral replication is upregulated by aberrant epigenetic modifications during influenza A virus infection. J. Immunol. 185, 5056-5065 (2010).
64. Ouyang, J. et al. NRAV, a long noncoding RNA, modulates antiviral responses through suppression of interferon-stimulated gene transcription. Cell Host Microbe 16, 616-626 (2014).
65. Basler, C. F. et al. The Ebola virus VP35 protein functions as a type I IFN antagonist. Proceedings of the National Academy of Sciences 97, 12289-12294 (2000).
66. Reid, S. P. et al. Ebola virus VP24 binds karyopherin alpha1 and blocks STAT1 nuclear accumulation. J. Virol. 80, 5156-5167 (2006).
67. Basler, C. F. & Amarasinghe, G. K. Evasion of interferon responses by Ebola and Marburg viruses. J Interferon Cytokine Res 29, 511-520 (2009).
68. Schumann, M., Gantke, T. & Muhlberger, E. Ebola virus VP35 antagonizes PKR activity through its C-terminal interferon inhibitory domain. J Virol 83, 8993-8997 (2009).
69. Mateo, M., Reid, S. P., Leung, L. W., Basler, C. F. & Volchkov, V. E. Ebolavirus VP24 binding to karyopherins is required for inhibition of interferon signaling. J. Virol. 84, 1169-1175 (2010).
70. Kubisch, R. et al. A Comprehensive Gene Expression Analysis of Resistance Formation upon Metronomic Cyclophosphamide Therapy. Transl Oncol 6, 1-9 (2013).
71. Nomiyama, T. et al. The NR4A orphan nuclear receptor NOR1 is induced by platelet-derived growth factor and mediates vascular smooth muscle cell proliferation. J. Biol. Chem. 281, 33467-33476 (2006).
72. Jin, L., Williamson, A., Banerjee, S., Philipp, I. & Rape, M. Mechanism of ubiquitin-chain formation by the human anaphasepromoting complex. Cell 133, 653-665 (2008).
73. Yao, J., Duan, L., Fan, M., Yuan, J. & Wu, X. Overexpression of BLCAP induces S phase arrest and apoptosis independent of p53 and NF-kappaB in human tongue carcinoma : BLCAP overexpression induces S phase arrest and apoptosis. Mol. Cell. Biochem. 297, 81-92 (2007).
74. Kondratowicz, A. S. et al. T-cell immunoglobulin and mucin domain 1 (TIM-1) is a receptor for Zaire Ebolavirus and Lake Victoria Marburgvirus. Proc. Natl. Acad. Sci. USA 108, 8426-8431 (2011).
75. Meertens, L. et al. The TIM and TAM families of phosphatidylserine receptors mediate dengue virus entry. Cell host & microbe 12, 544-557 (2012).
76. Pereira, N. L. et al. Natriuretic Peptide Receptor-3 Gene (NPR3) Nonsynonymous Polymorphism Results in Significant Reduction in Protein Expression Because of Accelerated Degradation. Circulation: Cardiovascular Genetics 6, 201-210 (2013).
77. Xu, W. et al. Ebola virus VP24 targets a unique NLS binding site on karyopherin alpha 5 to selectively compete with nuclear import of phosphorylated STAT1. Cell Host Microbe 16, 187-200 (2014).
78. Zhang, A. P. et al. The ebola virus interferon antagonist VP24 directly binds STAT1 and has a novel, pyramidal fold. PLoS Pathog. 8, e1002550 (2012).
79. Shabman, R. S., Gulcicek, E. E., Stone, K. L. & Basler, C. F. The Ebola virus VP24 protein prevents hnRNP C1/C2 binding to karyopherinp a1 and partially alters its nuclear import. J. Infect. Dis. 204 Suppl 3, S904-910 (2011).
80. Peltola, K. J. et al. Pim-1 kinase inhibits STAT5-dependent transcription via its interactions with SOCS1 and SOCS3. Blood 103, 3744-3750 (2004).
81. Piganis, R. A. et al. Suppressor of cytokine signaling (SOCS) 1 inhibits type I interferon (IFN) signaling via the interferon alpha receptor (IFNAR1)-associated tyrosine kinase Tyk2. J. Biol. Chem. 286, 33811-33818 (2011).
82. Liebermann, D. A. & Hoffman, B. Myeloid differentiation (MyD)/growth arrest DNA damage (GADD) genes in tumor suppression, immunity and inflammation. Leukemia 16, 527-541 (2002).
83. Novoa, I., Zeng, H., Harding, H. P. & Ron, D. Feedback inhibition of the unfolded protein response by GADD34-mediated dephosphorylation of eIF2alpha. J. Cell Biol. 153, 1011-1022 (2001).
84. Watanabe, R. et al. GADD34 inhibits mammalian target of rapamycin signaling via tuberous sclerosis complex and controls cell survival under bioenergetic stress. Int. J. Mol. Med. 19, 475-483 (2007).
85. Mukai, R. & Ohshima, T. HTLV-1 HBZ positively regulates the mTOR signaling pathway via inhibition of GADD34 activity in the cytoplasm. Oncogene 33, 2317-2328 (2014).
86. Lang, R., Hammer, M. & Mages, J. DUSP meet immunology: dual specificity MAPK phosphatases in control of the inflammatory response. J. Immunol. 177, 7497-7504 (2006).
87. Patterson, K. I., Brummer, T., OBrien, P. M. & Daly, R. J. Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochem. J. 418, 475-489 (2009).
88. Caceres, A. et al. Involvement of the cellular phosphatase DUSP1 in vaccinia virus infection. PLoS Pathog. 9, e1003719 (2013).
89. Arthur, J. S. & Ley, S. C. Mitogen-activated protein kinases in innate immunity. Nat. Rev. Immunol. 13, 679-692 (2013).
90. Weber, F., Kochs, G. & Haller, O. Inverse interference: how viruses fight the interferon system. Viral Immunol. 17, 498-515 (2004).
91. Carette, J. E. et al. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 477, 340-343 (2011).
92. Yuan, S. et al. TIM-1 acts a dual-attachment receptor for Ebolavirus by interacting directly with viral GP and the PS on the viral envelope. Protein & cell 6, 814-824 (2015).
93. Aleksandrowicz, P. et al. Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis. J. Infect. Dis. 204 Suppl 3, S957-967 (2011).
94. Nanbo, A. et al. Ebolavirus is internalized into host cells via macropinocytosis in a viral glycoprotein-dependent manner. PLoS Pathog. 6, e1001121 (2010).
95. Hoenen, T. et al. Inclusion bodies are a site of ebolavirus replication. J. Virol. 86, 11779-11788 (2012).
96. Mi, H., Poudel, S., Muruganujan, A., Casagrande, J. T. & Thomas, P. D. PANTHER version 10: expanded protein families and functions, and analysis tools. Nucleic acids research 44, D336-D342 (2016).
97. Chen, X. et al. Effect of Epstein-Barr virus reactivation on gene expression profile of nasopharyngeal carcinoma. Ai Zheng 27, 1-7 (2008).